| C8B |
C8B: Complement component C8 beta chain precursor |
PZP |
PZP: Pregnancy zone protein precursor |
0.275 |
Evidence |
|
| PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
ASPN |
ASPN: ASPN protein |
0.275 |
Evidence |
|
| PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
IGFBP7 |
IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor |
0.275 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
HSF2 |
HSF2, HSTF2: Heat shock factor protein 2 |
0.275 |
Evidence |
|
| CSF2 |
CSF2, GMCSF: Granulocyte-macrophage colony-stimulating factor precursor |
PROZ |
PROZ: Vitamin K-dependent protein Z precursor |
0.275 |
Evidence |
|
| RLN2 |
RLN2: Prorelaxin H2 precursor [Contains: Relaxin B chain; Relaxin A chain] |
IL12B |
IL12B, NKSF2: Interleukin-12 subunit beta precursor |
0.275 |
Evidence |
|
| C9 |
C9: Complement component C9 precursor [Contains: Complement component C9a; Compl |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.275 |
Evidence |
|
| A2M |
A2M, FWP007: Alpha-2-macroglobulin precursor |
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
0.275 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.275 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
0.275 |
Evidence |
|
| TXNDC |
TXNDC1, TMX, PSEC0085, TXNDC, UNQ235/PRO268: Thioredoxin domain-containing prote |
EPRS |
EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: |
0.275 |
Evidence |
|
| TXNDC |
TXNDC1, TMX, PSEC0085, TXNDC, UNQ235/PRO268: Thioredoxin domain-containing prote |
PIP5K3 |
PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase |
0.275 |
Evidence |
|
| FKBP10 |
FKBP10, FKBP65, PSEC0056: FK506-binding protein 10 precursor |
LAMB1 |
LAMB1: Laminin subunit beta-1 precursor |
0.275 |
Evidence |
|
| SF3A1 |
SF3A1, SAP114: Splicing factor 3 subunit 1 |
DPF2 |
DPF2, REQ, UBID4: Zinc finger protein ubi-d4 |
0.275 |
Evidence |
|
| SUZ12 |
SUZ12, CHET9, JJAZ1, KIAA0160: Polycomb protein SUZ12 |
SF3A1 |
SF3A1, SAP114: Splicing factor 3 subunit 1 |
0.275 |
Evidence |
|
| GRM3 |
GRM3, GPRC1C, MGLUR3: Metabotropic glutamate receptor 3 precursor |
APBA2 |
APBA2, MINT2, X11L: Amyloid beta A4 precursor protein-binding family A member 2 |
0.275 |
Evidence |
|
| KCNB1 |
KCNB1: Potassium voltage-gated channel subfamily B member 1 |
PLCB1 |
PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- |
0.275 |
Evidence |
|
| KCNJ12 |
KCNJ12, IRK2, KCNJN1: ATP-sensitive inward rectifier potassium channel 12 |
GRIN2C |
GRIN2C, NMDAR2C: Glutamate [NMDA] receptor subunit epsilon-3 precursor |
0.275 |
Evidence |
|
| TDG |
TDG: G/T mismatch-specific thymine DNA glycosylase |
SF3A1 |
SF3A1, SAP114: Splicing factor 3 subunit 1 |
0.275 |
Evidence |
|
| TIAM1 |
TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 |
KCNJ12 |
KCNJ12, IRK2, KCNJN1: ATP-sensitive inward rectifier potassium channel 12 |
0.275 |
Evidence |
|
| PRDX1 |
PRDX1, PAGA, PAGB, TDPX2: Peroxiredoxin-1 |
PDIA6 |
PDIA6, TXNDC7: Protein disulfide-isomerase A6 precursor |
0.275 |
Evidence |
|
| MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
PGAM1 |
PGAM1, PGAMA, CDABP0006: Phosphoglycerate mutase 1 |
0.275 |
Evidence |
|
| SUMO2 |
SUMO2, SMT3B, SMT3H2: Small ubiquitin-related modifier 2 precursor |
UBE2E3 |
UBE2E3, UBCE4, UBCH9: Ubiquitin-conjugating enzyme E2 E3 |
0.275 |
Evidence |
|
| CCT4 |
CCT4, CCTD, SRB: T-complex protein 1 subunit delta |
PDIA6 |
PDIA6, TXNDC7: Protein disulfide-isomerase A6 precursor |
0.275 |
Evidence |
|
| CCT6A |
CCT6A, CCT6, CCTZ: T-complex protein 1 subunit zeta |
TXNDC |
TXNDC1, TMX, PSEC0085, TXNDC, UNQ235/PRO268: Thioredoxin domain-containing prote |
0.275 |
Evidence |
|
- 
- 
-